These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32379748)

  • 21. Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy.
    Miname MH; Bittencourt MS; Moraes SR; Alves RIM; Silva PRS; Jannes CE; Pereira AC; Krieger JE; Nasir K; Santos RD
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1797-1804. PubMed ID: 30448145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.
    Rosenblit PD
    Curr Diab Rep; 2019 Jul; 19(8):61. PubMed ID: 31332544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Life satisfaction and the risk of atherosclerotic cardiovascular disease in the general Japanese population: the Suita Study.
    Arafa A; Kashima R; Kokubo Y
    Environ Health Prev Med; 2023; 28():62. PubMed ID: 37899209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast Arterial Calcification: A Potential Biomarker for Atherosclerotic Cardiovascular Disease Risk?
    Yoon YE; Yun B; Kim KM; Suh JW
    Curr Atheroscler Rep; 2021 Mar; 23(5):21. PubMed ID: 33772359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease in the Absence of Risk Factors.
    Whelton SP; McEvoy JW; Shaw L; Psaty BM; Lima JAC; Budoff M; Nasir K; Szklo M; Blumenthal RS; Blaha MJ
    JAMA Cardiol; 2020 Sep; 5(9):1011-1018. PubMed ID: 32936272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP
    J Am Heart Assoc; 2021 Aug; 10(16):e020551. PubMed ID: 34369182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Race and Ethnicity With Atherosclerotic Cardiovascular Disease Outcomes Within a Universal Health Care System: Insights From the CARTaGENE Study.
    d'Entremont MA; Ko D; Yan AT; Goodman SG; Ni J; Poirier P; Tardif JC; Grégoire JC; Couture ÉL; Nguyen M; Thanassoulis G; Sharma A; Huynh T
    Can J Cardiol; 2023 Jul; 39(7):925-932. PubMed ID: 36914033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Three Atherosclerotic Cardiovascular Disease Risk Scores With and Without Coronary Calcium for Predicting Revascularization and Major Adverse Coronary Events in Symptomatic Patients Undergoing Positron Emission Tomography-Stress Testing.
    Anderson JL; Le VT; Min DB; Biswas S; Minder CM; McCubrey RO; Knight S; Horne BD; Mason S; Lappe DL; Muhlestein JB; Knowlton KU
    Am J Cardiol; 2020 Feb; 125(3):341-348. PubMed ID: 31806210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of Incident Atherosclerotic Cardiovascular Disease Events and All-Cause Mortality in Patients With Age-Related Macular Degeneration: Prospective Cohort Study of UK Biobank.
    Wang Y; Liang Y; Seth I; Wu G; Du Z; Huang Y; Shang X; Liu S; Hu Y; Fang Y; Zhu Z; Hu Y; Zhang X; Yang X; Yu H
    Asia Pac J Ophthalmol (Phila); 2023 May-Jun 01; 12(3):293-302. PubMed ID: 37249901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between 5-year change in cardiovascular risk and the incidence of atherosclerotic cardiovascular diseases: a multi-cohort study.
    Yi J; Wang L; Guo X; Ren X
    J Transl Med; 2023 Sep; 21(1):589. PubMed ID: 37660053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease.
    Verweij SL; de Ronde MWJ; Verbeek R; Boekholdt SM; Planken RN; Stroes ESG; Pinto-Sietsma SJ
    J Clin Lipidol; 2018; 12(3):597-603.e1. PubMed ID: 29550494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of the Pooled Cohort atherosclerotic cardiovascular disease risk score in hepatitis C virus-infected persons.
    Chew KW; Bhattacharya D; Horwich TB; Yan P; McGinnis KA; Tseng C; Freiberg MS; Currier JS; Butt AA
    J Viral Hepat; 2017 Oct; 24(10):814-822. PubMed ID: 28273386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between diseases of despair and atherosclerotic cardiovascular disease among insured adults in the USA: a retrospective cohort study from 2017 to 2021.
    Nudy M; Galper K; George DR; Williams BA; Kraschnewski JL; Sinoway L; Brignone E
    BMJ Open; 2023 Sep; 13(9):e074102. PubMed ID: 37673458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of new scores for atherosclerotic cardiovascular disease using specific medical examination items: the Suita Study.
    Arafa A; Kashima R; Yasui Y; Kawachi H; Matsumoto C; Nosaka S; Teramoto M; Matsuo M; Kokubo Y
    Environ Health Prev Med; 2023; 28():61. PubMed ID: 37899208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.
    Mody P; Joshi PH; Khera A; Ayers CR; Rohatgi A
    J Am Coll Cardiol; 2016 May; 67(21):2480-7. PubMed ID: 27230043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT): a prospective longitudinal study protocol investigating the prevalence, severity and determinants of atherosclerotic cardiovascular disease in the young adult Pakistani population.
    Hanif B; Sheikh S; Peerwani G; Cainzos-Achirica M; Javed W; Baqar JB; Samad Z; Bashir F; S Virani S; Nasir K; Aijaz S
    BMJ Open; 2023 Nov; 13(11):e076045. PubMed ID: 37984941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and incidence of atherosclerotic cardiovascular disease and its risk factors in Korea: a nationwide population-based study.
    Kim H; Kim S; Han S; Rane PP; Fox KM; Qian Y; Suh HS
    BMC Public Health; 2019 Aug; 19(1):1112. PubMed ID: 31412823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project.
    Han C; Liu F; Yang X; Chen J; Li J; Cao J; Li Y; Shen C; Yu L; Liu Z; Wu X; Zhao L; Hu D; Lu X; Wu X; Gu D
    Sci China Life Sci; 2018 May; 61(5):504-514. PubMed ID: 29721777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults.
    Ma Y; Li S; Yang H; Zhang Y; Li H; Zhou L; Lin J; Chen Y; Hou Y; Zhang X; Liu T; Zhou X; Wang Y
    Atherosclerosis; 2022 Oct; 358():47-54. PubMed ID: 36113328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims database.
    Zhao Z; Zhu Y; Fang Y; Ye W; McCollam P
    J Med Econ; 2015; 18(9):655-65. PubMed ID: 25891183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.